rofecoxib has been researched along with Intestinal Neoplasms in 1 studies
Intestinal Neoplasms: Tumors or cancer of the INTESTINES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshima, M | 1 |
| Murai, N | 1 |
| Kargman, S | 1 |
| Arguello, M | 1 |
| Luk, P | 1 |
| Kwong, E | 1 |
| Taketo, MM | 1 |
| Evans, JF | 1 |
1 other study available for rofecoxib and Intestinal Neoplasms
| Article | Year |
|---|---|
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Topics: Animals; Anticarcinogenic Agents; beta Catenin; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inh | 2001 |